Travatan

Travatan Use In Pregnancy & Lactation

travoprost

Manufacturer:

Novartis

Distributor:

Zuellig
/
Firma Chun Cheong
Full Prescribing Info
Use In Pregnancy & Lactation
Women of child-bearing potential/contraception: TRAVATAN eye drops must not be used in women of child bearing age/potential unless adequate contraceptive measures are in place (see Pharmacology: Toxicology: Preclinical safety data under Actions).
Pregnancy: Travoprost has harmful pharmacological effects on pregnancy and/or the fetus/new-born child.
TRAVATAN eye drops should not be used during pregnancy unless clearly necessary.
Breastfeeding: It is unknown whether travoprost from the eye drops is excreted in human breast milk. Animal studies have shown excretion of travoprost and metabolites in breast milk. The use of TRAVATAN eye drops by breast-feeding mothers is not recommended.
Fertility: There are no data on the effects of TRAVATAN eye drops on human fertility. Animal studies showed no effect of travoprost on fertility at doses more than 250 times the maximum recommended human ocular dose.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in